Leveraging Development Strengths Drives Therapies to Market

December 16, 2013

Cynthia A. Challener

Cynthia A. Challener, PhD, is a contributing editor to BioPharm International.

BioPharm International, BioPharm International-12-16-2013, Volume 2013 eBook, Issue 1

NPS Pharmaceuticals uses its expertise in development, regulatory compliance, and commercialization to bring to market products with orphan drug status.

Established biopharmaceutical company NPS Pharmaceuticals uses its expertise in development, regulatory compliance, and commercialization to bring to market products with orphan drug status.

Read this article from BioPharm International’s 2013 Innovation Updates and Strategies eBook.

View other articles in the 2013 Innovation Updates and Strategies eBook.